P3 Health Partner a Aktie
WKN DE: A3C80E / ISIN: US7444131053
14.08.2025 23:11:52
|
P3 Health Partners Posts Q2 Revenue Drop
P3 Health Partners (NASDAQ:PIII), a physician-led healthcare group focused on value-based care for Medicare Advantage members, reported results for Q2 FY2025 on August 14, 2025. The most notable news was a miss on both top- and bottom-line expectations: revenue (GAAP) came in slightly below analyst projections at $355.8 million, while diluted earnings per share (EPS) posted a GAAP loss of $(6.23). The deeper-than-expected adjusted EBITDA loss (non-GAAP) and ongoing decline in at-risk membership highlighted the company’s operational challenges. Both revenue (GAAP) and EPS (non-GAAP) fell short of consensus estimates by small but material amounts. The quarter reflected progress in medical cost management, but overall results pointed to persistent weaknesses that the company has yet to fully address. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. P3 Health Partners specializes in coordinating care for Medicare Advantage members using a value-based care model. This approach focuses on improving patient health outcomes and lowering costs, rather than billing for each service. The company operates largely by partnering with primary care physicians, providing care management and support through its own technology platform.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu P3 Health Partners Inc Registered Shs -A-mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu P3 Health Partners Inc Registered Shs -A-mehr Analysen
Aktien in diesem Artikel
Q2 Holdings Inc | 57,00 | 0,00% |
|